lilly mazdutide vs novo semaglutide Innovent and Lilly's Outperforms in Phase 3 DREAMS-3 Trial with Superior Glycemic Control and Weight Loss Mazdutide outperforms Semaglutide in type
Description
Out-Of-Pocket Costs Without Insurance Without insurance, GLP-1 drugs such as Wegovy and Zepbound can cost more than $1,000 per month, making them inaccessible for many patients
Slowing of Gastric Emptying GLP-1 delays the movement of food from the stomach to the small intestine
They are referenced here only to describe what grey-market devices look like, not as recommendations
You dont have to figure it out alone
The downsides of microdosing GLP-1s The main downside is that you likely wont see results quite as quickly as you would with a higher dose
